Class IIReported 2025-10-22

Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by: AstraZeneca AB, Sweden, Distributed by: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. NDC 0310-1730-30

Recalled by ASTRAZENECA PHARMACEUTICALS

Reason for Recall

Lack of Assurance of Sterility:

Recall Number

D-0028-2026

Classification

Class II

Status

Ongoing

Category

drug

Initiated

2025-10-08

Reported

2025-10-22

Distribution

Nationwide in the U.S

Code Info

Lot YJ0152, Expiry: 01/31/2028.

Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.